Skip to main content
. 2023 Dec 28;10(2):220–226. doi: 10.1001/jamaoncol.2023.5757

Figure 4. Two-Year Graft-vs-Host Disease–Free and Relapse-Free Survival (GRFS) and Overall Survival in the Mesenchymal Stem Cell (MSC) and Control Groups.

Figure 4.

HR indicates hazard ratio.